Literature DB >> 3499376

Macrophage-neutrophil interactions: contrasting effects of the monokines interleukin-1 and tumour necrosis factor (cachectin) on human neutrophil adherence.

W K Seow1, Y H Thong, A Ferrante.   

Abstract

Incubation of human neutrophils with recombinant human interleukin-1 alpha (IL-1 alpha) resulted in the suppression of neutrophil adherence. In contrast, similar treatment with recombinant human tumour necrosis factor-alpha (TNF alpha, cachectin) resulted in the enhancement of neutrophil adherence. These contrasting effects were noted as early as 5 min after incubation, and persisted for at least 60 min. Simultaneous addition of these two monokines resulted in intermediate values between suppression by IL-1 and enhancement by TNF alpha. The stimulatory effects of the chemotactic peptide FMLP and the phorbol ester PMA were ameliorated by IL-1 but augmented by TNF alpha. The effects of these monokines on neutrophil adherence were abolished by heating but not by polymyxin B treatment, showing that their modulatory properties were not mediated by endotoxin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3499376      PMCID: PMC1454138     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  Effect of 24 antimicrobial drugs on polymorphonuclear leukocyte adherence.

Authors:  S Y Li; W K Seow; Y H Thong
Journal:  Int Arch Allergy Appl Immunol       Date:  1985

2.  Macrophage tumor killing: influence of the local environment.

Authors:  J B Hibbs; R R Taintor; H A Chapman; J B Weinberg
Journal:  Science       Date:  1977-07-15       Impact factor: 47.728

Review 3.  Cachectin: more than a tumor necrosis factor.

Authors:  B Beutler; A Cerami
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

4.  Enhancement of human MLR by very low concentrations of lipopolysaccharide and blocking of this enhancement by polymyxin B.

Authors:  G T Spear; M Teodorescu
Journal:  J Immunol Methods       Date:  1984-10-26       Impact factor: 2.303

Review 5.  The role of protein kinase C in cell surface signal transduction and tumour promotion.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1984 Apr 19-25       Impact factor: 49.962

6.  Development of a microassay technique for neutrophil adherence.

Authors:  Y H Thong; J M Currell
Journal:  J Immunol Methods       Date:  1983-10-14       Impact factor: 2.303

7.  Separation of mononuclear and polymorphonuclear leucocytes from human blood by the one-step Hypaque-Ficoll method is dependent on blood column height.

Authors:  A Ferrante; Y H Thong
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

8.  Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator.

Authors:  R H Weisbart; D W Golde; S C Clark; G G Wong; J C Gasson
Journal:  Nature       Date:  1985 Mar 28-Apr 3       Impact factor: 49.962

9.  Mononuclear cell-mediated enhancement of granulocyte function in man.

Authors:  M A Vadas; N Nicola; A F Lopez; D Metcalf; G Johnson; A Pereira
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

10.  Enhancement of base hexose-monophosphate shunt activity of human polymorphonuclear leucocytes by human beta-interferon.

Authors:  A Ferrante; V O Rencis
Journal:  Immunol Lett       Date:  1984       Impact factor: 3.685

View more
  13 in total

1.  Neutrophil-mediated cartilage injury in vitro is enhanced by tumour necrosis factor alpha.

Authors:  I C Kowanko; E J Bates; A Ferrante
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

2.  Tumor necrosis factor enhances neutrophil-mediated killing of Plasmodium falciparum.

Authors:  L M Kumaratilake; A Ferrante; C M Rzepczyk
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

3.  Morphological study in the early stages of complement C5a fragment-induced experimental meningitis: activation of macrophages and astrocytes.

Authors:  P M Faustmann; D Krause; R Dux; R Dermietzel
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

4.  Comparison of abilities of recombinant interleukin-1 alpha and -beta and noninflammatory IL-1 beta fragment 163-171 to upregulate C3b receptors (CR1) on human neutrophils and to enhance their phagocytic capacity.

Authors:  J D Ogle; J G Noel; A Balasurbramaniam; R M Sramkoski; C K Ogle; J W Alexander
Journal:  Inflammation       Date:  1990-04       Impact factor: 4.092

5.  Characterization of the major neutrophil-stimulating activity present in culture medium conditioned by Staphylococcus aureus-stimulated mononuclear leucocytes.

Authors:  E J Bates; A Ferrante; L J Beard
Journal:  Immunology       Date:  1991-03       Impact factor: 7.397

6.  Tetrandrine, a plant alkaloid, inhibits the production of tumour necrosis factor-alpha (cachectin) hy human monocytes.

Authors:  A Ferrante; W K Seow; B Rowan-Kelly; Y H Thong
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

7.  Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus.

Authors:  E Roilides; A Dimitriadou-Georgiadou; T Sein; I Kadiltsoglou; T J Walsh
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  Disparate effects of interferon-gamma and tumor necrosis factor-alpha on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro.

Authors:  R D Diamond; C A Lyman; D R Wysong
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

9.  Modulation of transmembrane signalling in HL-60 granulocytes by tumour necrosis factor-alpha.

Authors:  K R McLeish; J B Klein; T Schepers; G Sonnenfeld
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

10.  Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils.

Authors:  C J Horvath; T J Ferro; G Jesmok; A B Malik
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.